These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 39195228)

  • 1. Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target.
    Marschall M; Schütz M; Wild M; Socher E; Wangen C; Dhotre K; Rawlinson WD; Sticht H
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interactive Complex between Cytomegalovirus Kinase vCDK/pUL97 and Host Factors CDK7-Cyclin H Determines Individual Patterns of Transcription in Infected Cells.
    Schütz M; Cordsmeier A; Wangen C; Horn AHC; Wyler E; Ensser A; Sticht H; Marschall M
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency.
    Schütz M; Wangen C; Sommerer M; Kögler M; Eickhoff J; Degenhart C; Klebl B; Naing Z; Egilmezer E; Hamilton ST; Rawlinson WD; Sticht H; Marschall M
    Virus Res; 2023 Oct; 335():199200. PubMed ID: 37591314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations.
    Wild M; Hahn F; Brückner N; Schütz M; Wangen C; Wagner S; Sommerer M; Strobl S; Marschall M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Conserved Interaction Profiles between Clinically Relevant Mutants of the Cytomegalovirus CDK-like Kinase pUL97 and Human Cyclins: Functional Significance of Cyclin H.
    Schütz M; Müller R; Socher E; Wangen C; Full F; Wyler E; Wong D; Scherer M; Stamminger T; Chou S; Rawlinson WD; Hamilton ST; Sticht H; Marschall M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97.
    Steingruber M; Keller L; Socher E; Ferre S; Hesse AM; Couté Y; Hahn F; Büscher N; Plachter B; Sticht H; Marschall M
    J Biol Chem; 2019 Apr; 294(15):6188-6203. PubMed ID: 30782840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Relevance of the Interaction between Human Cyclins and the Cytomegalovirus-Encoded CDK-Like Protein Kinase pUL97.
    Schütz M; Steingruber M; Socher E; Müller R; Wagner S; Kögel M; Sticht H; Marschall M
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34198986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies.
    Obergfäll D; Wild M; Sommerer M; Barillas Dahm M; Kicuntod J; Tillmanns J; Kögler M; Lösing J; Dhotre K; Müller R; Wangen C; Wagner S; Phan QV; Wiebusch L; Briestenská K; Mistríková J; Kerr-Jones L; Stanton RJ; Voigt S; Hahn F; Marschall M
    Pharmaceutics; 2024 Sep; 16(9):. PubMed ID: 39339274
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.
    Bigley TM; Reitsma JM; Terhune SS
    J Virol; 2015 Oct; 89(20):10230-46. PubMed ID: 26223645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins.
    Steingruber M; Kraut A; Socher E; Sticht H; Reichel A; Stamminger T; Amin B; Couté Y; Hutterer C; Marschall M
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27548200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory roles of protein kinases in cytomegalovirus replication.
    Marschall M; Feichtinger S; Milbradt J
    Adv Virus Res; 2011; 80():69-101. PubMed ID: 21762822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cytomegalovirus Protein Kinase pUL97:Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting.
    Steingruber M; Marschall M
    Microorganisms; 2020 Apr; 8(4):. PubMed ID: 32260430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain.
    Steingruber M; Socher E; Hutterer C; Webel R; Bergbrede T; Lenac T; Sticht H; Marschall M
    Viruses; 2015 Aug; 7(8):4582-601. PubMed ID: 26270673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins.
    Graf L; Webel R; Wagner S; Hamilton ST; Rawlinson WD; Sticht H; Marschall M
    Viruses; 2013 Dec; 5(12):3213-30. PubMed ID: 24351800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.
    Webel R; Hakki M; Prichard MN; Rawlinson WD; Marschall M; Chou S
    J Virol; 2014 May; 88(9):4776-85. PubMed ID: 24522923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.
    Reitsma JM; Savaryn JP; Faust K; Sato H; Halligan BD; Terhune SS
    Cell Host Microbe; 2011 Feb; 9(2):103-14. PubMed ID: 21320693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity.
    Rechter S; Scott GM; Eickhoff J; Zielke K; Auerochs S; Müller R; Stamminger T; Rawlinson WD; Marschall M
    J Biol Chem; 2009 Mar; 284(13):8605-13. PubMed ID: 19179338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97.
    Marschall M; Stein-Gerlach M; Freitag M; Kupfer R; van den Bogaard M; Stamminger T
    J Gen Virol; 2001 Jun; 82(Pt 6):1439-1450. PubMed ID: 11369889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.
    Piret J; Boivin G
    Antiviral Res; 2019 Mar; 163():91-105. PubMed ID: 30690043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers.
    Wild M; Karner D; Eickhoff J; Wagner S; Kicuntod J; Chang W; Barry P; Jonjić S; Lenac Roviš T; Marschall M
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.